Furthermore, in a study of over 5,200 men that also includes those with localized disease, adrenal-permissive HSD3B1 allele homozygosity is associated with a higher risk of prostate cancer death, thus making it the most common monogenic link to prostate cancer mortality (16, 17). Here, HSD3B1 is linked to prostate carcinoma.